Lily Searle | Fieldfisher
Skip to main content
Professional background

Professional background

I am a Director in Fieldfisher's Corporate team, specialising in Equity Capital Markets. I have experience of both Main Market and AIM IPO's, fundraisings and acquisitions. I regularly act for issuers and investment banks alike and am confident in negotiating each aspect of a transaction. I am happy to advise on discrete questions concerning matters of corporate law and governance and have a particular interest in life sciences and renewables. During 2023/2024, I spent eight months on secondment with the in-house legal team of investment bank, Liberum Capital. Whilst there, I sat within the investment banking room and additionally supported the internal team on Liberum’s merger with Panmure Gordon.

Education

Education

University of Warwick: LLB (Hons) Law 2011-2014

I earned an Upper Second Class Honours degree from the University of Warwick

Notable deals

Notable deals

Advised Allenby Capital, Dowgate Capital & Stifel Nicolaus Europe

Advised Allenby Capital, Dowgate Capital & Stifel Nicolaus Europe on the c£100m fundraising and acquisition for Franchise Brands plc

Advised Berenberg & Tamesis

Advised Berenberg & Tamesis on their Main Market £40m fundraising and Class 1 transaction for Capital Limited

Advised CT Automotive Group plc

Advised CT Automotive Group plc on their initial public offering and subsequent fundraises

Advised EnSilica plc

Advised EnSilica plc on their placing and admission to AIM

Advised Gelion plc

Advised Gelion plc on their initial public offering and all subsequent fundraises

Advised InnovaDerma plc

Advised InnovaDerma plc on their Main Market Placing and Open Offer, and subsequently on their recommended merger with Brand Architekts Group plc

Advised Panmure Gordon

Advised Panmure Gordon on the AIM IPO of Dianomi

Advised SigmaRoc plc

Advised SigmaRoc plc in connection with a £260 million fundraising to fund the €470 million acquisition of Finnish limestone producer Nordkalk Corporation

Advised Stifel and Cenkos

Advised Stifel and Cenkos on the AIM IPO of GENinCode

Advised Synairgen

Advised Synairgen on their £87m Placing, US Placing & Open Offer to fund their Phase III Clinical Trials, representing one of the largest biotech fundraisings on AIM for several years

Authored pieces

All Resources
A digital landscape showcasing undulating neon lines in shades of pink, purple, and blue against a black background. The lines create a sense of depth and movement, evoking a futuristic or virtual environment. Small glowing particles are scattered throughout.
Press Release

Fieldfisher advises Atome plc on £25 million UK fundraising to support flagship green fertiliser project

19.05.2026
European law firm Fieldfisher has advised Atome plc, a leading low-carbon fertiliser developer, on its UK fundraising, comprising a placing, subscription and retail offer that raised just over £25 million.
Learn more
Press Release

Fieldfisher advises Gelion plc on £10.5 million oversubscribed fundraise

07.11.2025
Learn more
A large open-pit mine with tiered levels, illuminated by several bright lights, stretches across the foreground under a colorful sky at sunset. In the distance, city lights twinkle, blending with the vibrant hues of the sky.
Energy and Natural Resources
Insight

Fieldfisher Mining and Metals Team advises on matters worth US$2.1bn in 2023

01.02.2024
Learn more
Two large heavy-duty trucks positioned on a rocky construction or mining site. The trucks, facing away from each other, show dusty tires and an open bed, surrounded by a landscape of rocks under a blue sky with scattered clouds.
Press Release

Fieldfisher acts for SigmaRoc on US$1.1bn reverse takeover, £200 million fundraising and re-admission to AIM

23.11.2023
Learn more
Insight

Will FCA board diversity targets lead to meaningful change?

20.11.2023
Two years since the FCA set out proposals for improving diversity and inclusion on company boards and executive committees, Fieldfisher hosted a retrospective workshop on the challenges of making boards of directors more diverse.
Learn more